Gene · 6443
Papers1,640
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,640
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Successful use of methylene blue following out of hospital cardiac arrest: a case report. | Eur Heart J Case Rep | 2026 | 41728236 | PubTator, text mining | PubMed |
| Pulmonary Venous Vasculopathy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension With Reduced Diffusion Capacity for Carbon Monoxide. | Pulm Circ | 2026 | 41727705 | PubTator, text mining | PubMed |
| Differential cardiovascular benefits of SGLT2 inhibitors, sacubitril/valsartan, omecamtiv mecarbil, and vericiguat across heart failure phenotypes: a systematic review and meta-analysis. | Front Pharmacol | 2026 | 41727549 | PubTator, text mining | PubMed |
| Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons. | Eur Respir Rev | 2026 | 41708122 | PubTator, text mining | PubMed |
| Antihypertensive therapy in diabetes mellitus: efficacy, safety, and metabolic impacts in type 1 and type 2 diabetes. | Cardiovasc Diabetol Endocrinol Rep | 2026 | 41703653 | PubTator, text mining | PubMed |
| Capillary-Associated Microglia in Neurovascular Coupling: Localization, Mechanisms, and Disease Implications. | J Neuroinflammation | 2026 | 41668173 | PubTator, text mining | PubMed |
| The Impact of Glycosylation on the Conformational Ensembles of β-, δ-, and γ Sarcoglycans. | bioRxiv | 2026 | 41648567 | PubTator, text mining | PubMed |
| S-Nitrosation-Based Target Discovery and Drug Development: Toward a Nitric Oxide Drug 2.0 Paradigm. | J Med Chem | 2026 | 41621016 | PubTator, text mining | PubMed |
| Early Methylene Blue for Mortality Reduction in High-Dose VasoPREssor-Dependent Septic Shock (EMPRESS): protocol for a multicenter randomized controlled trial. | Scand J Trauma Resusc Emerg Med | 2026 | 41580807 | PubTator, text mining | PubMed |
| No QTcF Prolongation with Sepiapterin: Results From a Thorough QT Study in Healthy Subjects at Therapeutic and Supratherapeutic Doses. | J Clin Pharmacol | 2026 | 41532446 | PubTator, text mining | PubMed |
| Beta-3 Adrenoreceptor Agonist Mirabegron Improves Right Ventricular Function in a Rat Monocrotaline-Induced Pulmonary Hypertension Model. | Pulm Circ | 2026 | 41532037 | PubTator, text mining | PubMed |
| NO-driven self-propelled nanomotors with deep biofilm penetration for synergistic therapy of peri-implantitis. | Mater Today Bio | 2026 | 41492644 | PubTator, text mining | PubMed |
| Response to Comment on: Heme reduces corpus cavernosum smooth muscle contraction via the HO-CO-sGC-cGMP pathway: implications for priapism in sickle cell disease. | Int J Impot Res | 2026 | 41407895 | PubTator, text mining | PubMed |
| Searching for blood biomarkers and treatment targets in Women with fibromyalgia - Protein interaction patterns and anti-satellite glia cell IgG antibodies as promising candidates. | Brain Behav Immun | 2026 | 41271190 | PubTator, text mining | PubMed |
| Pharmacokinetic and Pharmacodynamic Evaluation of Bidridistrogene Xeboparvovec in an Aged Murine Model of Limb-Girdle Muscular Dystrophy Type 2E/R4. | Hum Gene Ther | 2026 | 41194675 | PubTator, text mining | PubMed |
| Comment on: Heme, the HO-CO-sGC-cGMP pathway, and corpus cavernosum contractility: new insights into the pathophysiology of priapism in sickle cell disease. | Int J Impot Res | 2026 | 41145709 | PubTator, text mining | PubMed |
| A Founder Allele in SGCG Combining Missense Variant and Multi-Exon Duplication in Turkish Patients With Sarcoglycanopathy. | Clin Genet | 2026 | 40785021 | PubTator, text mining | PubMed |
| Drug-loaded nanoparticles reduced platelet aggregation and blood coagulation. | Front Med Technol | 2025 | 41716478 | PubTator, text mining | PubMed |
| Pompe disease: a country-wide molecular screening in a cohort of 15,068 study participants. | Front Mol Biosci | 2025 | 41695778 | PubTator, text mining | PubMed |
| Gasotransmitter signaling in the brain: New frontiers for therapeutics. | Neurotherapeutics | 2025 | 41188152 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6443/papers?page=3